The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis

References

• Shahi SK, Freedman SN, Mangalam AK. Gut microbiome in multiple sclerosis: the players involved and the roles they play. Gut Microbes. 2017;8(6):607–615. doi: 10.1080/19490976.2017.1349041
   PubMed Web of Science ®Google Scholar
• Gilmour H, Ramage-Morin PL, Wong SL Health reports multiple sclerosis: prevalence and impact. www.statcan.gc.ca.
   Google Scholar
• Schepici G, Silvestro S, Bramanti P, et al. The gut microbiota in multiple sclerosis: an overview of clinical trials. Cell Transplant. 2019;28(12):1507–1527. doi: 10.1177/0963689719873890
   PubMed Web of Science ®Google Scholar
• Walton C, King R, Rechtman L. Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition. Mult Scler. 2020;26(14):1816–1821. doi: 10.1177/1352458520970841
   PubMed Web of Science ®Google Scholar
• Amankwah N. Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts. Health Prom Chron Dis Prev Can. 2017;37(2):37–48. doi: 10.24095/hpcdp.37.2.02
   PubMed Web of Science ®Google Scholar
• Jangi S, Ghandi R, Cox LM. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016;7(1):12015. doi: 10.1038/ncomms12015
   PubMed Web of Science ®Google Scholar
• Zou S, Fang L, Lee MH. Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterol Rep. 2018;6(1):1–12. doi: 10.1093/gastro/gox031
   Google Scholar
• de Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol. 2018;195(1):74–85. doi: 10.1111/cei.13158
   Web of Science ®Google Scholar
• Matsuoka K, Mizuno S, Hayashi A, et al. Fecal microbiota transplantation for gastrointestinal diseases. Keio J Med. 2014;63(4):69–74. doi: 10.2302/kjm.2014-0006-RE
   PubMedGoogle Scholar
• Sabus A, Merrow M, Heiden A, et al. Fecal microbiota transplantation for treatment of severe Clostridioides difficile colitis in a pediatric patient with non-Hodgkin lymphoma. J Pediatr Hematol Oncol. 2021;43(6):897–899. doi: 10.1097/MPH.0000000000002023.
   Web of Science ®Google Scholar
• Belvoncikova P, Maronek M, Gardlik R. Gut dysbiosis and fecal microbiota transplantation in autoimmune diseases. Int J Mol Sci. 2022;23(18):10729. doi: 10.3390/ijms231810729.
   PubMed Web of Science ®Google Scholar
• Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, et al. A comprehensive review on the role of the gut microbiome in human neurological disorders. Clin Microbiol Rev. 2022;35(1):33820. doi: 10.1128/CMR.00338-20
   Web of Science ®Google Scholar
• Wang HX, Wang YP. Gut microbiota-brain axis. Chin Med J. 2016;129(19):2373–2380. doi: 10.4103/0366-6999.190667
   PubMed Web of Science ®Google Scholar
• Weissert R. The immune pathogenesis of multiple sclerosis. J Neuro Pharmacol. 2013;8(4):857–866. doi: 10.1007/s11481-013-9467-3
   PubMed Web of Science ®Google Scholar
• Beecham AH, Patsopoulos NA, Xifara DK. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45:1353–1362.
   PubMed Web of Science ®Google Scholar
• Correale J, Gaitán MI. Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection. Acta Neurol Scand. 2015;132:46–55. doi: 10.1111/ane.12431
   PubMed Web of Science ®Google Scholar
• Legroux L, Arbour N. Multiple sclerosis and T lymphocytes: an entangled story. J Neuroimmune Pharmacol. 2015;10(4):528–546. doi: 10.1007/s11481-015-9614-0
   PubMed Web of Science ®Google Scholar
• Choi HH, Cho YS. Fecal microbiota transplantation: current applications, effectiveness, and future perspectives. Clin Endosc. 2016;49(3):257–265. doi: 10.5946/ce.2015.117
   PubMed Web of Science ®Google Scholar
• Smits LP, Bouter KEC, de Vos WM. Therapeutic potential of fecal microbiota transplantation. Gastroenterol. 2013;145(5):946–953. doi: 10.1053/j.gastro.2013.08.058
   PubMed Web of Science ®Google Scholar
• Pomares Bascuñana RA, Veses V, Sheth CC. Effectiveness of fecal microbiota transplant for the treatment of Clostridioides difficile diarrhea: a systematic review and meta‐analysis. Lett Appl Microbiol. 2021;73(2):149–158. doi: 10.1111/lam.13486.
   PubMed Web of Science ®Google Scholar
• Berer K, Gerdes LA, Cekanaviciute E. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Nat Acad Sci. 2017;114(40):10719–10724. doi: 10.1073/pnas.1711233114.
   PubMed Web of Science ®Google Scholar
• Cekanaviciute E, Yoo BB, Runia TA. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Nat Acad Sci. 2017;114(40):10713–10718. doi: 10.1073/pnas.1711235114
   PubMed Web of Science ®Google Scholar
• Li K, Wei S, Hu L. Protection of fecal microbiota transplantation in a mouse model of multiple sclerosis. Med Inflammation. 2020;8:2058272. doi: 10.1155/2020/2058272
   Google Scholar
• Al KF, Craven LJ, Gibbons S. Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: a pilot randomized controlled trial. Mult Scler J Exp Transl Clin. 2022;8(2):2055–2062. doi: 10.1177/20552173221086662.
   Google Scholar
• Makkawi S, Camara-Lemarroy C, Metz L. Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS. Neurol(r) Neuroimmunol Neuroinflammation. 2018;5(4):459–463. doi: 10.1212/NXI.0000000000000459
   PubMed Web of Science ®Google Scholar
• Borody T, Campbell J, Torres M, et al. Reversal of idiopathic thrombocytopenic purpura [itP] with fecal microbiota transplantation [FMT] in multiple sclerosis (MS). 2004. www.amjgastro.com.
   Google Scholar
• Engen PA, Zaferiou A, Rasmussen H, et al. Single-arm, non-randomized, timeseries, single-subject study of fecal microbiota transplantation in multiple sclerosis. Front Neurol. 2020;11:1–11.
   PubMed Web of Science ®Google Scholar
• Wu N, Li W, Ma H, et al. The role of gut microbiota and fecal microbiota transplantation in neuroimmune diseases. Front Neurol. 2023;14:1–11. doi: 10.3389/fneur.2023.1108738
   Web of Science ®Google Scholar
• MathesRon JAT, Holsinger RMD. The role of fecal microbiota transplantation in the treatment of neurodegenerative diseases: a review. Int J Molecular Sci. 2023;24(2):1–17. doi: 10.3390/ijms24021001
   Web of Science ®Google Scholar